Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, Endocervical Curettage Test, and HPV Test), By Age Group (Age 20–40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023

Code : CMI3994

Pages :220

Formats :

Excel and PDF

Industry : Clinical Diagnostic

Market News

Global Cervical Cancer Diagnostic Tests Market- Key Developments

On March 07 2023, Roche Products (India) Pvt. Ltd., a suppliers & service providers of Diagnostic & Therapeutic products, announced the signing of a Memorandum of Understanding (MoU) with the Cancer Awareness Prevention and Early Detection Trust (CAPED), a non-profit organisation dedicated to promoting cancer awareness, prevention, and early detection. The partnership with CAPED is part of Roche’s broader commitment to improving cancer care globally. The company has a long-standing legacy of innovation in cancer diagnostics and therapies, and has been at the forefront to develop new approaches to cancer care.

In April 2021, Hologic, Inc., an innovative medical technology company announced that its new Genius Digital Diagnostics System is now commercially available in Europe. The Genius Digital Diagnostics System is the next generation of cervical cancer screening that combines deep learning-based artificial intelligence (AI) with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells in women. It was developed to provide actionable insights, and improve workflow and lab efficiency, all with one goal in mind – to eradicate cervical cancer.

In November 2022, the (Malinauskas) Australia Government, has launched a ‘You Can Do It’ campaign to encourage women aged 25 to 74 to consider self-collection for its five yearly screening. Self-collection is all about giving women choice and control. Wellbeing SA (Sothern Australia), a state government agency leading a focus and action on prevention has also partnered with Cancer Council to fund training for (General Practitioner) GPs in self-collection to ensure women across the state are supported to choose the best option for them when it comes to cervical screening.

In May 2022, U.S. Department of Health and Human Services (HHS), announced the availability of US$ 5 million for community health centers, funded by HHS’s Health Resources and Services Administration, to increase equitable access to life-saving cancer screenings. This funding supports President Joe Biden’s Unity Agenda and his call to action on cancer screening and early detection as part of the Administration’s Cancer Moonshot initiative to end cancer as we know it.